U.S. Markets close in 41 mins

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.93-0.24 (-1.97%)
As of 3:18PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 394.17
52 Week Low 310.76
50-Day Moving Average 330.14
200-Day Moving Average 327.86

Share Statistics

Avg Vol (3 month) 34.29M
Avg Vol (10 day) 321.4M
Shares Outstanding 582.74M
Implied Shares Outstanding 6N/A
Float 849.08M
% Held by Insiders 118.48%
% Held by Institutions 158.09%
Shares Short (Apr 14, 2021) 44.25M
Short Ratio (Apr 14, 2021) 411.26
Short % of Float (Apr 14, 2021) 45.66%
Short % of Shares Outstanding (Apr 14, 2021) 45.14%
Shares Short (prior month Mar 14, 2021) 42.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin -22.51%
Operating Margin (ttm)24.70%

Management Effectiveness

Return on Assets (ttm)1.70%
Return on Equity (ttm)-3.86%

Income Statement

Revenue (ttm)48.63M
Revenue Per Share (ttm)2.25
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)33.65M
Net Income Avi to Common (ttm)-10.95M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)850.12M
Total Cash Per Share (mrq)10.27
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.73
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)296.73M
Levered Free Cash Flow (ttm)315.21M